Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06258551 · ClinicalTrials.gov registry record
Dynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill Patients
A clinical trial of Clostridium Difficile and Antibiotic Resistant Infection, sponsored by The Methodist Hospital Research Institute.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 2
- Study locations
NCT06258551 is a study of Clostridium Difficile and Antibiotic Resistant Infection that is actively recruiting participants, run by The Methodist Hospital Research Institute. The registered enrollment target is 1,000 participants, above the 295-participant average among 6 other Clostridium Difficile trials with a reported enrollment target (239% higher). The trial reports 2 study locations across 1 state.
The verdict
NCT06258551, a study of Clostridium Difficile and Antibiotic Resistant Infection, is actively recruiting participants, sponsored by The Methodist Hospital Research Institute.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this observational study is to investigate how bacterial populations from the intestine and mouth of patients change during the hospitalization period and evaluate if some populations of specific bacteria increase or decrease the risk of acquiring an infection or becoming colonized by pathogenic bacteria. Participants will have the following samples collected during enrollment: stool samples (maximum 2x/week), blood draws (1x/week), oral swab (1x/week).
Conditions Studied
Study Locations (2)
Texas
- Houston Methodist Hospital - Houston
- The University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2020-12-08 |
| Est. Completion | 2026-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06258551
The ClinicalTrials.gov registry entry for NCT06258551 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 295-participant average among 6 other Clostridium Difficile trials with a reported enrollment target (239% higher). The listed sponsor is The Methodist Hospital Research Institute, which has 126 total studies on file at ClinicalTrials.gov.
The record links to 8 conditions, with Clostridium Difficile appearing as the primary indexed condition, and to 0 interventions.
NCT06258551 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06258551 about?
NCT06258551 is a clinical study titled "Dynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill Patients". The goal of this observational study is to investigate how bacterial populations from the intestine and mouth of patients change during the hospitalization period and evaluate if some populations of specific bacteria increase or decrease the risk of acquiring an infection or becoming colonized by pa...
What is the current status of trial NCT06258551?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2020-12-08. Estimated completion is 2026-06.
What conditions does trial NCT06258551 study?
This clinical trial studies the following conditions: Clostridium Difficile, Antibiotic Resistant Infection, Antimicrobial Drug Resistance, Vancomycin Resistant Enterococci Infection, Carbapenem Resistant Bacterial Infection.
Who is sponsoring clinical trial NCT06258551?
This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06258551 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Clostridium Difficile
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
RECRUITING · Phase 3
-
REMBRANDT: REcovery of the MicroBiome fRom Antibiotics for Dental implanTs
ACTIVE NOT RECRUITING
-
SER-109 Versus Placebo to Prevent Recurrent Clostridium Difficile Infection (RCDI)
COMPLETED · Phase 2
-
Dose-Confirmation, Immunogenicity and Safety Study of the Clostridium Difficile Vaccine Candidate VLA84 in Healthy Adults Aged 50 Years and Older. Phase II Study
COMPLETED · Phase 2
-
Study of Nitazoxanide in the Treatment of Clostridium Difficile Colitis
COMPLETED · Phase 2
-
Early FMT for C.Difficile
COMPLETED · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.